Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772152022> ?p ?o ?g. }
- W2772152022 endingPage "18" @default.
- W2772152022 startingPage "13" @default.
- W2772152022 abstract "Oncologists tend to avoid the use of supplements during chemotherapy. To understand the safety issue, a literature review was conducted to evaluate safety and possible benefits of taking curcumin during chemotherapy. Curcumin was chosen because of its wide use in the public and because of the availability of clinical trials utilizing curcumin during chemotherapy. Curcumin is considered a “pan-assay interference compound,” creating false leads in drug discovery assays. The pharmacodynamics of curcumin presents many challenges for a therapeutic agent, including poor bioavailability and rapid metabolism and excretion. The proposed molecular targets for curcumin include inhibition of nuclear factor kappa B and inhibition of cyclooxygenase-2. Clinical trials investigating the efficacy of curcumin treatment for cancer have been conducted in patients with colorectal cancer (CRC), pancreatic cancer, breast cancer, prostate cancer, multiple myeloma, lung cancer, and head and neck cancer. Outcomes revealed that while curcumin was not effective, it was well tolerated and safe. Recently, there have been several Phase I and Phase II trials combining curcumin with chemotherapeutic agents. Two trials investigated the effect of curcumin given concurrently with gemcitabine for advanced pancreatic cancer patients. One trial investigated the effect of curcumin given concurrently with docetaxel in advanced breast cancer patients. Another trial investigated the role of curcumin given concurrently with docetaxel and prednisone in castration-resistant prostate cancer patients. The results again indicate the safety of curcumin, but no added benefit of adding curcumin to the chemotherapy regimen. The literature review demonstrated that curcumin is well tolerated up to 6–8 g in research. While there are many promising in vivo and in vitro trials on the potential benefits of curcumin for treatment of cancer in conjunction with chemotherapy, to date there is no evidence that combining curcumin with chemotherapeutic agents is effective for treating cancer in humans. The lack of effect may be due to the target diseases that are treatment resistant such as advanced pancreatic cancer and advanced breast cancer. Also, curcumin has many difficult properties such as poor solubility and rapid metabolism. Currently, there are developments of analogues, liposomal products, and nanoparticles that may overcome the current challenges of curcumin. Future studies should utilize these evolving technologies." @default.
- W2772152022 created "2017-12-22" @default.
- W2772152022 creator A5041583773 @default.
- W2772152022 creator A5077043709 @default.
- W2772152022 creator A5077288970 @default.
- W2772152022 creator A5083846747 @default.
- W2772152022 date "2018-02-01" @default.
- W2772152022 modified "2023-09-25" @default.
- W2772152022 title "Effectiveness of Curcumin for Treating Cancer During Chemotherapy" @default.
- W2772152022 cites W1604068141 @default.
- W2772152022 cites W1842944210 @default.
- W2772152022 cites W1971808737 @default.
- W2772152022 cites W1976194786 @default.
- W2772152022 cites W1997149430 @default.
- W2772152022 cites W2002207325 @default.
- W2772152022 cites W2010573152 @default.
- W2772152022 cites W2019520069 @default.
- W2772152022 cites W2020430786 @default.
- W2772152022 cites W2031394131 @default.
- W2772152022 cites W2037987072 @default.
- W2772152022 cites W2041210949 @default.
- W2772152022 cites W2041544048 @default.
- W2772152022 cites W2050823452 @default.
- W2772152022 cites W2083623093 @default.
- W2772152022 cites W2088242076 @default.
- W2772152022 cites W2092032160 @default.
- W2772152022 cites W2095032594 @default.
- W2772152022 cites W2095569714 @default.
- W2772152022 cites W2096098783 @default.
- W2772152022 cites W2103059478 @default.
- W2772152022 cites W2108706315 @default.
- W2772152022 cites W2121411068 @default.
- W2772152022 cites W2129397604 @default.
- W2772152022 cites W2135731245 @default.
- W2772152022 cites W2135770108 @default.
- W2772152022 cites W2138508372 @default.
- W2772152022 cites W2154574630 @default.
- W2772152022 cites W2154748960 @default.
- W2772152022 cites W2159626225 @default.
- W2772152022 cites W2161015285 @default.
- W2772152022 cites W2165088640 @default.
- W2772152022 cites W2236275528 @default.
- W2772152022 cites W2324360643 @default.
- W2772152022 cites W2579340176 @default.
- W2772152022 doi "https://doi.org/10.1089/act.2017.29147.yhk" @default.
- W2772152022 hasPublicationYear "2018" @default.
- W2772152022 type Work @default.
- W2772152022 sameAs 2772152022 @default.
- W2772152022 citedByCount "12" @default.
- W2772152022 countsByYear W27721520222019 @default.
- W2772152022 countsByYear W27721520222020 @default.
- W2772152022 countsByYear W27721520222021 @default.
- W2772152022 countsByYear W27721520222022 @default.
- W2772152022 crossrefType "journal-article" @default.
- W2772152022 hasAuthorship W2772152022A5041583773 @default.
- W2772152022 hasAuthorship W2772152022A5077043709 @default.
- W2772152022 hasAuthorship W2772152022A5077288970 @default.
- W2772152022 hasAuthorship W2772152022A5083846747 @default.
- W2772152022 hasConcept C121608353 @default.
- W2772152022 hasConcept C126322002 @default.
- W2772152022 hasConcept C143998085 @default.
- W2772152022 hasConcept C2776256026 @default.
- W2772152022 hasConcept C2776694085 @default.
- W2772152022 hasConcept C2778250585 @default.
- W2772152022 hasConcept C2780192828 @default.
- W2772152022 hasConcept C2780210213 @default.
- W2772152022 hasConcept C2780258809 @default.
- W2772152022 hasConcept C2781190966 @default.
- W2772152022 hasConcept C530470458 @default.
- W2772152022 hasConcept C535046627 @default.
- W2772152022 hasConcept C71924100 @default.
- W2772152022 hasConcept C98274493 @default.
- W2772152022 hasConceptScore W2772152022C121608353 @default.
- W2772152022 hasConceptScore W2772152022C126322002 @default.
- W2772152022 hasConceptScore W2772152022C143998085 @default.
- W2772152022 hasConceptScore W2772152022C2776256026 @default.
- W2772152022 hasConceptScore W2772152022C2776694085 @default.
- W2772152022 hasConceptScore W2772152022C2778250585 @default.
- W2772152022 hasConceptScore W2772152022C2780192828 @default.
- W2772152022 hasConceptScore W2772152022C2780210213 @default.
- W2772152022 hasConceptScore W2772152022C2780258809 @default.
- W2772152022 hasConceptScore W2772152022C2781190966 @default.
- W2772152022 hasConceptScore W2772152022C530470458 @default.
- W2772152022 hasConceptScore W2772152022C535046627 @default.
- W2772152022 hasConceptScore W2772152022C71924100 @default.
- W2772152022 hasConceptScore W2772152022C98274493 @default.
- W2772152022 hasIssue "1" @default.
- W2772152022 hasLocation W27721520221 @default.
- W2772152022 hasOpenAccess W2772152022 @default.
- W2772152022 hasPrimaryLocation W27721520221 @default.
- W2772152022 hasRelatedWork W2003256833 @default.
- W2772152022 hasRelatedWork W2029505291 @default.
- W2772152022 hasRelatedWork W2080820783 @default.
- W2772152022 hasRelatedWork W2090986497 @default.
- W2772152022 hasRelatedWork W2151941897 @default.
- W2772152022 hasRelatedWork W2301049861 @default.
- W2772152022 hasRelatedWork W2315587357 @default.
- W2772152022 hasRelatedWork W2380565576 @default.